Numinus Advances Phase 1 Trial on Proprietary Psilocybin Product

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/12/2026

1. ORCL
2. ADBE
3. RH
4. SPY
5. CPRT
6. ACVA
7. SEDG
8. SPCX
9. TLT
10. PMTS

Go back to Numinus Advances Phase 1 Trial on Proprietary Psilocybin Product
(AMEX: LKYSD) Delayed: 0.33 --0 (-0%)
Previous Close $0.33    52 Week High $0.04 
Open $0.89    52 Week Low $0.04 
Day High $0.33    P/E N/A 
Day Low $0.33    EPS $0.00 
Volume 0       

(NYSE: NUMI) Delayed: 24.17 +0.11 (0.46%)
Previous Close $24.06    52 Week High $ 
Open $24.12    52 Week Low $ 
Day High $24.28    P/E N/A 
Day Low $24.12    EPS $ 
Volume 5,857